@article{BoelchStreckPlumhoffetal.2020,
  author    = {Boelch, Sebastian Philipp and Streck, Laura Elisa and Plumhoff, Piet and Konrads, Christian and Gohlke, Frank and Rueckl, Kilian},
  title     = {Infection control and outcome of staged reverse shoulder arthroplasty for the management of shoulder infections},
  series = {JSES International},
  volume    = {4},
  journal   = {JSES International},
  doi       = {10.1016/j.jseint.2020.08.012},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-230620},
  pages     = {959-963},
  year      = {2020},
  abstract  = {Background The treatment of septic arthritis, caused by either hematogenous seeding, injections, or surgery, can be challenging. Staged reverse shoulder arthroplasty (RSA) with temporary implantation of an antibiotic-loaded spacer is widely accepted but still discussed controversially. This study investigated the shoulder-specific bacterial spectrum, infection control rate, functional outcome, and infection-free survival rate after staged RSA in the mid- to long-term follow-up. It was hypothesized that staged RSA would show a high infection-free survival rate. Methods A total of 39 patients treated with staged RSA for primary septic arthritis (n = 8), secondary infection (n = 8), or periprosthetic infection (n = 23) were retrospectively included. The infection control rate was calculated based on cultures taken intraoperatively at spacer removal and RSA implantation. Infection-free survival was defined as no revision due to infection. The minimum follow-up period for functional outcome assessment was 2 years (n = 14; mean, 76 months; range, 31-128 months). Results Cutibacterium (26\%) and coagulase-negative staphylococci (23\%) were the predominant pathogens. The infection control rate was 90\%. The cumulative infection-free survival rate was 91\% after 128 months. Follow-up examinations showed a mean Constant score of 48 (range, 7-85), a mean QuickDASH (short version of Disabilities of the Arm, Shoulder and Hand questionnaire) score of 40.0 (range, 11.4-93.3), and a mean pain score of 1.6 (range, 0-7). Conclusion Staged RSA implantation was confirmed to be a reliable treatment option for primary, secondary, and periprosthetic infections of the shoulder. The infection control rate and infection-free survival rate are satisfactory. However, patients and surgeons must be aware of functional impairment even after successful treatment of infections.},
  language  = {en}
}